Corpus Intelligence IC Memo — WESLACO REGIONAL REHABILITATION HOSP 2026-04-26 15:55 UTC
IC Memo — WESLACO REGIONAL REHABILITATION HOSP
Investment Committee Memorandum | TX | 32 beds | Grade D | EBITDA uplift $780K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

WESLACO REGIONAL REHABILITATION HOSP

CCN 453091 | HIDALGO, TX | 32 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

WESLACO REGIONAL REHABILITATION HOSP is a 32-bed community hospital in HIDALGO, TX with $10.5M in net patient revenue and a -3.1% operating margin. The hospital serves a payer mix of 44.0% Medicare, 0.0% Medicaid, and 56.0% commercial.

Thesis: Turnaround. Our ML models identify $780K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.1% to 4.3% (+741bps).

Net Revenue HCRIS$10.5M
Current EBITDA COMPUTED$-324K
Operating Margin COMPUTED-3.1%
Occupancy HCRIS61.5%
Revenue / Bed COMPUTED$329K
Net-to-Gross HCRIS60.1%
Distress Probability MLnan%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
273
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of -3.1% places it below the state median. Among 273 size-comparable peers (16-64 beds), the median margin is -3.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (16-64), prioritizing same-state peers. 273 hospitals in the comp set.

HospitalStateBedsRevenueMargin
WESLACO REGIONAL REHABILITATIO (Target)TX32$10.5M-3.1%
WISE HEALTH SYSTEM - PARKWAYTX36$361.0M-15.5%
CORYELL MEMORIAL HOSPITALTX25$305.9M-1.5%
BAYLOR HEART AND VASCULAR HOSPTX53$255.0M30.0%
TEXAS ORTHOPEDIC HOSPITATX42$237.8M46.3%
LAKE GRANBURY MEDICAL CENTERTX53$181.6M38.5%
METHODIST HOSPITAL FOR SURGERYTX32$178.4M22.8%
TEXAS SPINE AND JOINT HOSPITALTX20$147.3M30.3%
NORTH CENTRAL SURGICAL HOSPITATX24$143.6M32.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $780K (741bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$221K+210bp18mo
Denial Rate Reduction12.0%6.5%$211K+200bp12mo
Cost to Collect4.5%2.5%$210K+200bp12mo
A/R Days Reduction5200.0%3800.0%$128K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+9bp6mo

5. EBITDA Bridge

Net Collection Rate
$221K
Denial Rate Reduction
$211K
Cost to Collect
$210K
A/R Days Reduction
$128K
Clean Claim Rate
$10K
Total EBITDA Uplift$780K
Current EBITDA$-324K
+ RCM Uplift+$780K
Pro Forma EBITDA$455K
Current Margin-3.1%
Pro Forma Margin4.3%
WC Released (1x)$404K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-499K$5.7M0.00x-100.0%
Base (11x exit)10.0x11.0x$-499K$6.1M0.00x-100.0%
Bull Case9.0x11.0x$-449K$8.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-449K$9.1M0.00x-100.0%
Bear Case11.0x10.0x$-549K$1.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-549K$1.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 273 hospitals with 16-64 beds
  • Same-state prioritization (n=274)
  • Comp margins: P25=-28.9% / P50=-3.9% / P75=10.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.